Start > News > News

News

Press Release: Phadia AB expands its offering in the field of antidrug antibody (ADA) testing and personalized medicine - through a collaboration with Biomonitor A/S » »
8/23/2011

Uppsala, Sweden and Copenhagen, Denmark, August 22, 2011 Phadia AB and Biomonitor A/S announced today a collaboration in the field of immunogenicity ... »
Phadia announces first-ever commercial availability of peanut allergen component tests »
8/16/2011

uKnow Peanut Test™, a new, more precise peanut allergy test, provides physicians and patients molecular level clarity to aid in the diagnosis and help assess the risk of allergic ... »
Phadia at the largest Clinical Lab Expo in the World »
7/1/2011

Phadia will be present at the AACC 2011 Conference at the Georgia Congress Center, July 26–28. »
Phadia First Company To Receive FDA Clearance Of Recombinant Allergen Component Tests »
6/20/2011

510(k) clearance covers 13 molecular allergen components. Newly-available tests provide deepest clinical insight into peanut allergy, as well as allergies to cat dander, dust ... »
Landmark Study Affirms The Clinical Utility of ImmunoCAP Allergy Testing »
5/27/2011

"Allergies Across America” Health Trends Report Published by Quest Diagnostics Spotlights the Importance of Allergy Diagnosis and Treatment to halt the allergic march to asthma, ... »
New Guidelines Confirm The Significant Role of ImmunoCAP Specific IgE Test In The Diagnosis And Management of Food Allergy »
12/15/2010

Phadia is on the cutting edge of advancing the understanding of immunology with the development of Innovative allergen component testing »
Phadia Receives FDA 510(k) Clearance »
9/21/2010

New EliA® assays will allow the laboratory unmatched performance and simplicity to provide physicians better tools to diagnose and manage celiac disease. »
September Asthma Epidemic Lurks »
9/17/2010

Asthma deaths and hospitalizations peak 17 days after Labor Day; easy-to-implement preventive measures can save lives, help people with asthma breathe easier »